Project Details
Short title | NOSTRA-Feasibility study: A prospective non-randomised multi-centre feasibility study to assess if patients with residual cancer following dual-targeted neoadjuvant chemotherapy treatment for HER2-positive, ER-negative early breast cancer.. |
---|---|
Status | Active |
Effective start/end date | 1/01/18 → 31/12/25 |
Funding
- ROCHE PRODUCTS LIMITED